Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
1994-3-28
pubmed:abstractText
The effect of dexamethasone (DEX) on Eimeria mivati infection in chickens was examined. Chickens given an extended DEX treatment produced significantly higher numbers of total oocysts following primary and secondary infections with E. mivati. Chickens treated with DEX intramuscularly or orally showed lower body weight gain in E. mivati infected or uninfected chickens as compared with the untreated group. Chickens given DEX intramuscularly showed a lower number of splenic lymphocytes. Flow cytometric analysis of lymphocyte composition revealed that the percentages of splenic lymphocytes bearing CD8 (cytotoxic-suppressor T cells), gamma delta T cell receptor (TCR 1), class II major histocompatibility or surface IgM antigens in DEX-treated chickens were lower than in controls, whereas the percentages of T lymphocytes expressing CD3, CD4 (helper T cells) or alpha beta TCR antigens were significantly higher. Furthermore, concanavalin A-induced lymphoproliferation, interleukin-2 (IL-2) and gamma-interferon (gamma-IFN) production by spleen lymphocytes were generally depressed in DEX-treated chickens. IL-2 production of E. mivati-infected chickens given oral DEX was significantly lower compared with the uninfected-DEX-treated group. Uninfected chickens treated with DEX intramuscularly showed a significantly lower gamma-IFN production compared with other uninfected groups. In contrast, serum IgG levels were enhanced in DEX-treated, E. mivati-infected chickens compared with untreated, infected chickens. These results suggest that enhanced disease susceptibility to coccidiosis in DEX-treated chickens may reflect a drug-mediated immunosuppression of cell-mediated immunity.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0165-2427
pubmed:author
pubmed:issnType
Print
pubmed:volume
39
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
431-46
pubmed:dateRevised
2003-11-14
pubmed:meshHeading
pubmed-meshheading:8116219-Animals, pubmed-meshheading:8116219-Antibodies, Monoclonal, pubmed-meshheading:8116219-Chickens, pubmed-meshheading:8116219-Coccidiosis, pubmed-meshheading:8116219-Cytokines, pubmed-meshheading:8116219-Dexamethasone, pubmed-meshheading:8116219-Disease Susceptibility, pubmed-meshheading:8116219-Eimeria, pubmed-meshheading:8116219-Enzyme-Linked Immunosorbent Assay, pubmed-meshheading:8116219-Feces, pubmed-meshheading:8116219-Flow Cytometry, pubmed-meshheading:8116219-Histocompatibility Antigens Class II, pubmed-meshheading:8116219-Immunity, Cellular, pubmed-meshheading:8116219-Immunoglobulin M, pubmed-meshheading:8116219-Immunosuppression, pubmed-meshheading:8116219-Lymphocyte Activation, pubmed-meshheading:8116219-Parasite Egg Count, pubmed-meshheading:8116219-Poultry Diseases, pubmed-meshheading:8116219-Receptors, Antigen, T-Cell, pubmed-meshheading:8116219-T-Lymphocyte Subsets, pubmed-meshheading:8116219-Weight Gain
pubmed:year
1993
pubmed:articleTitle
Dexamethasone suppresses T cell-mediated immunity and enhances disease susceptibility to Eimeria mivati infection.
pubmed:affiliation
USDA, Agricultural Research Service, Beltsville Agricultural Research Center, MD 20705.
pubmed:publicationType
Journal Article